WO2007081301A3 - Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii - Google Patents

Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii Download PDF

Info

Publication number
WO2007081301A3
WO2007081301A3 PCT/US2005/046783 US2005046783W WO2007081301A3 WO 2007081301 A3 WO2007081301 A3 WO 2007081301A3 US 2005046783 W US2005046783 W US 2005046783W WO 2007081301 A3 WO2007081301 A3 WO 2007081301A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel
identification
methods
toxoplasma gondii
protein isolated
Prior art date
Application number
PCT/US2005/046783
Other languages
French (fr)
Other versions
WO2007081301A2 (en
Inventor
Alan Sher
Felix Yarovinsky
Original Assignee
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America As Represented By The Secretary Of Health And Human Services, Nih filed Critical The United States Of America As Represented By The Secretary Of Health And Human Services, Nih
Publication of WO2007081301A2 publication Critical patent/WO2007081301A2/en
Publication of WO2007081301A3 publication Critical patent/WO2007081301A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the identification of a novel IL-12 inducing protein isolated from Toxoplasma gondii, and to methods of using the novel protein for modulating immune responses.
PCT/US2005/046783 2005-01-06 2005-12-21 Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii WO2007081301A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64142905P 2005-01-06 2005-01-06
US60/641,429 2005-01-06

Publications (2)

Publication Number Publication Date
WO2007081301A2 WO2007081301A2 (en) 2007-07-19
WO2007081301A3 true WO2007081301A3 (en) 2010-05-06

Family

ID=38256743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/046783 WO2007081301A2 (en) 2005-01-06 2005-12-21 Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii

Country Status (1)

Country Link
WO (1) WO2007081301A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120189581A1 (en) * 2009-07-24 2012-07-26 Schultz-Cherry Stacey L Use of toxoplasma and derived compositions to prevent or treat microbial infections
US20130280297A1 (en) * 2012-04-11 2013-10-24 Lori Neal Use of toxoplasma gene products to prevent or treat microbial infections
JPWO2014034046A1 (en) * 2012-08-27 2016-08-08 国立大学法人帯広畜産大学 Vaccine preparation against Toxoplasma infection
IT201900016736A1 (en) * 2019-09-19 2021-03-19 Takis S R L Fused antigens to the Toxoplasma Gondii Profilin-like protein (PFTG) and their use in preventive and therapeutic vaccination.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010040A1 (en) * 2003-07-15 2005-02-03 Barros Research Institute Eimeria tenella antigen for immunotherapy of coccidiosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005010040A1 (en) * 2003-07-15 2005-02-03 Barros Research Institute Eimeria tenella antigen for immunotherapy of coccidiosis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LAUW ET AL: "Of mice and man: TLR11 (finally) finds profilin", TRENDS IN IMMUNOLOGY, vol. 26, no. 10, 1 October 2005 (2005-10-01), pages 509 - 511, XP005073862, ISSN: 1471-4906 *
YAROVINSKY F ET AL: "Toll-like receptor recognition of Toxoplasma gondii", INTERNATIONAL JOURNAL OF PARASITOLOGY, vol. 36, no. 3, 1 March 2006 (2006-03-01), pages 255 - 259, XP025241611, ISSN: 0020-7519, [retrieved on 20060301] *
YAROVINSKY FELIX ET AL: "TLR11 activation of dendritic cells by a protozoan profilin-like protein.", SCIENCE, vol. 308, no. 5728, 10 June 2005 (2005-06-10), pages 1626 - 1629, XP002571249, ISSN: 1095-9203 *

Also Published As

Publication number Publication date
WO2007081301A2 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
WO2007033221A3 (en) Methods and compositions for inhibition of immune responses
HUS1800021I1 (en) Human anti-il-23 antibodies, compositions, methods and uses
WO2006033859A3 (en) Compositions and methods for protein production
WO2006093524A3 (en) Antigen-carbohydrate conjugates
WO2006029094A3 (en) Erythropoietin derivatives with altered immunogenicity
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2005056759A3 (en) Methods of generating variant proteins with increased host string content and compositions thereof
WO2006017538A3 (en) Hk1-binding proteins
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
EP2275448A3 (en) Monovalent antibody fragments useful as therapeutics
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
WO2006069719A3 (en) Lyophilization of virosomes
WO2004108894A3 (en) Methods and compositions for amino acid production
WO2007087053A3 (en) Bmp-7 variant compositions, methods and uses
WO2005074973A3 (en) Method of inducing or modulating immune response
WO2007081301A3 (en) Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii
AU2003234198A8 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
AU2002360330A1 (en) Identifying and reducing the allergenicity of food proteins
WO2007073567A3 (en) Compositions and methods of modulating the immune response
ZA200408272B (en) Compositions for improving the flavor of alcoholicbeverage made from grape.
EP1532177A4 (en) Immunomodulatory constructs and their uses
WO2004078936A3 (en) Methods for preventing gluconoylation of proteins
WO2008147426A3 (en) Methods and compositions for immunomodulation
AU2005904831A0 (en) Novel method of modulating immune function
GB2406094B (en) Modified antibody comprising an amino acid substitution mutation which confers increased stability

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 05858724

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 05858724

Country of ref document: EP

Kind code of ref document: A2